Raveendra-Panickar Dhanya
Sanford Burnham Prebys Medical Discovery Institute(US)Discovery Institute(US)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Receptor Mechanisms and Signaling, Cytokine Signaling Pathways and Interactions, Protein Tyrosine Phosphatases, Galectins and Cancer Biology
Most-Cited Works
- → Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates(2015)710 cited
- → Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids(2015)55 cited
- → Design and Synthesis of an Orally Active Metabotropic Glutamate Receptor Subtype-2 (mGluR2) Positive Allosteric Modulator (PAM) That Decreases Cocaine Self-Administration in Rats(2010)53 cited
- → Potent, Selective, and Orally Available Benzoisothiazolone Phosphomannose Isomerase Inhibitors as Probes for Congenital Disorder of Glycosylation Ia(2011)47 cited
- → Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence(2014)40 cited
- → A Disalicylic Acid‐Furanyl Derivative Inhibits Ephrin Binding to a Subset of Eph Receptors(2011)40 cited
- → Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure–Activity Relationships and Assessment in a Rat Model of Nicotine Dependence(2012)26 cited
- → A cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors(2020)25 cited
- → Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cells(2021)11 cited
- Design, synthesis and evaluation of novel group II metabotropic glutamate receptor allosteric modulators in rodent models of CNS disorders(2014)